Vicore Pharma Holding AB (publ) Cash Flow Reinvestment Rate

Latest as of March 2024: 3.03x

Vicore Pharma Holding AB (publ) cash flow reinvestment rate. Vicore Pharma Holding AB (publ) (VICO) has a Cash Flow Reinvestment Rate of 3.03x as of March 2024, reinvesting Skr70.00 Million (capex Skr0.00 plus investments Skr70.00 Million) from operating cash flow of Skr23.08 Million. Explore Vicore Pharma Holding AB (publ) cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

3.03x

(Capex + Investments) / Operating CF

Total Reinvested

Skr70.00 Million

Capex + Investments

Operating Cash Flow

Skr23.08 Million

SEK

Capital Expenditures

Skr0.00

SEK

Vicore Pharma Holding AB (publ) Cash Flow Reinvestment Rate by Year (None–None)

Vicore Pharma Holding AB (publ) cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Vicore Pharma Holding AB (publ). For the full cash flow conversion analysis, see VICO cash generation efficiency.

Year	Reinvestment Rate	Total Reinvested (SEK)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow